Literature DB >> 2770778

Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy.

D A Krendel1, H P Parks, D C Anthony, M B St Clair, D G Graham.   

Abstract

We compared histologic features of sural nerve biopsies in 14 patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with those in other forms of neuropathy. In CIDP endoneurial pericapillary cellular infiltrates were found in 4 patients (29%), onion bulbs in 5 patients (36%), and predominant demyelination in 7 patients (50%). None of these abnormalities was specific, but cellular infiltrates and onion bulbs appear to be diagnostically useful when combined with clinical information. To detect macrophage infiltration of myelin, cell nuclei were counter-stained in 20 teased fiber preparations. Nine patients with CIDP had a significantly higher mean number of cells per centimeter of teased fiber than 11 patients with other neuropathies. Despite overlap, significant infiltration of myelin detected by this method suggests CIDP in an appropriate clinical setting.

Entities:  

Mesh:

Year:  1989        PMID: 2770778     DOI: 10.1002/mus.880120402

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

1.  The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.

Authors:  Alain Créange; Arnold Careyron
Journal:  J Neurol       Date:  2013-09-20       Impact factor: 4.849

2.  Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.

Authors:  Jacqueline A Hawkins-Salsbury; Lauren Shea; Xuntian Jiang; Daniel A Hunter; A Miguel Guzman; Adarsh S Reddy; Elizabeth Y Qin; Yedda Li; Steven J Gray; Daniel S Ory; Mark S Sands
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

3.  Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Chaoling Dong; Kelsey M Greathouse; Rebecca L Beacham; Steven P Palladino; E Scott Helton; Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2017-02-16       Impact factor: 5.330

4.  Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.

Authors:  D S Molenaar; M Vermeulen; R de Haan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

5.  Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy.

Authors:  W Schady; P J Goulding; B R Lecky; R H King; C M Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

6.  Chronic inflammatory demyelinating polyneuropathy in childhood: clinical and electrophysiological features.

Authors:  A Uncini; E Parano; D J Lange; D C De Vivo; R E Lovelace
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

7.  Chronic inflammatory demyelinating polyneuropathy or hereditary motor and sensory neuropathy? Diagnostic value of morphological criteria.

Authors:  A A Gabreëls-Festen; F J Gabreëls; J E Hoogendijk; P A Bolhuis; P J Jongen; H M Vingerhoets
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 8.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

Review 9.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

10.  Nodes of ranvier and paranodes in chronic acquired neuropathies.

Authors:  Carmen Cifuentes-Diaz; Odile Dubourg; Theano Irinopoulou; Marc Vigny; Sylvie Lachkar; Laurence Decker; Patrick Charnay; Natalia Denisenko; Thierry Maisonobe; Jean-Marc Léger; Karine Viala; Jean-Jacques Hauw; Jean-Antoine Girault
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.